StockData
Aptevo Therapeutics Inc. logo

Aptevo Therapeutics Inc. (APVO) stock

APVONasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$0.45−0.02 (-3.25%)

Close on Nov 18, 2026Market cap $803.68KP/E –Yield –

Aptevo Therapeutics total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Aptevo Therapeutics's total debt was $3.46M at Dec 31, 2022. For fiscal 2022 it was $3.46M, down 77.5% from the year before. The highest annual figure on record is $19.86M in fiscal 2019.

Annual total debt

PeriodPeriod endValueChange
FY2022Dec 31, 2022$3.46M-77.5%
FY2021Dec 31, 2021$15.37M+207.5%
FY2020Dec 31, 2020$5.00M-74.8%
FY2019Dec 31, 2019$19.86M+3.0%
FY2018Dec 31, 2018$19.28M+1.1%
FY2017Dec 31, 2017$19.06M+3.7%
FY2016Dec 31, 2016$18.38M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2022Dec 31, 2022$3.46M-77.5%
Q3 FY2022Sep 30, 2022$3.91M-65.0%
Q2 FY2022Jun 30, 2022$2.00M-81.3%
Q1 FY2022Mar 31, 2022$2.00M-80.3%
Q4 FY2021Dec 31, 2021$15.37M+207.5%
Q3 FY2021Sep 30, 2021$11.17M-43.8%
Q2 FY2021Jun 30, 2021$10.67M-45.5%
Q1 FY2021Mar 31, 2021$10.17M-47.6%
Q4 FY2020Dec 31, 2020$5.00M-74.1%
Q4 FY2019Dec 31, 2019$19.86M+3.8%
Q2 FY2019Jun 30, 2019$19.56M-0.0%
Q1 FY2019Mar 31, 2019$19.42M+0.6%
Q4 FY2018Dec 31, 2018$19.28M+1.1%
Q3 FY2018Sep 30, 2018$19.14M+9.5%
Q2 FY2018Jun 30, 2018$19.57M+4.4%
Q1 FY2018Mar 31, 2018$19.31M+4.7%
Q4 FY2017Dec 31, 2017$19.06M+3.7%
Q3 FY2017Sep 30, 2017$17.48M-3.5%
Q2 FY2017Jun 30, 2017$18.75M–
Q1 FY2017Mar 31, 2017$18.44M–
Q4 FY2016Dec 31, 2016$18.38M–
Q3 FY2016Sep 30, 2016$18.11M–

More Aptevo Therapeutics figures

See a number that looks wrong?